Publications - Phar LLC

Featured Publications

Burden of Living with Migraine: Results for United States from the “My Migraine Voice” Survey

Gibbs SN, Shah S, Deshpande CG, Vo P, Bensink ME, Broder MS, Lipton RB

American Headache Society

2019

Download

Early initiation of long-acting injectable antipsychotic treatment is associated with lower hospitalization rates and healthcare costs in patients with schizophrenia: real-world evidence from US claims data

Munday J, Greene M, Chang E, Hartry A, Yan T, Broder MS

Current Medical Research and Opinion

2019

Download

Systematic bias in predictions of new drugs’ budget impact: analysis of a sample of recent US drug launches

Broder MS, Zambrano J, Lee J, Marken RS

Current Medical Research and Opinion

2018

Download

Severity Classification for Sickle Cell Disease: A RAND/UCLA Modified Delphi Panel

Shah N, Beenhouwer D, Broder MS, Bronte-Hall L, De Castro LM, Gibbs SN, Gordeuk VR, Kanter J, Klings ES, Lipato T, Manwani D, Scullin B, Yermilov I, Smith WR

61st ASH Annual Meeting & Exposition

2019

Download

2020

Hospital Share of Profits from Physician-Administered Medicines

Download Publication

2020

Projected Lifetime Clinical Value of a Multicancer Early Detection Test

Download Publication

2020

Real-World Impact of Disease on Functioning and Activity: A Cross-Sectional Study of the National Health and Nutrition Examination Survey

Download Publication

2020

The economic burden of caregiving in epilepsy: An estimate based on a survey of US caregivers

Download Publication

2019

Costs associated with unplanned readmissions among patients with heart failure with and without hyponatremia

Download Publication

2019

Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United States

Download Publication

2019

How does the Cox maze procedure compare? Cost-effectiveness analysis of alternative treatments of atrial fibrillation

Download Publication

2019

Modeling the Mortality Impact of Budget Thresholds

Download Publication

2019

Protecting the gains: What changes are needed to prevent a reversal of the downward cardiovascular disease mortality trend?

Download Publication

2018

A Conversational War of Attrition

Download Publication

2018

Bending the curve with patient identification and treatment in osteoporosis

Download Publication

2018

Budget impact analysis of long-acting injectable aripiprazole once-monthly 400 mg in bipolar I disorder in the USA

Download Publication

2018

Cost-effectiveness of long-acting injectable aripiprazole once-monthly 400 mg in bipolar I disorder in the USA

Download Publication

2018

Defining Value-Based Pricing of Drugs

Download Publication

2018

Systematic bias in predictions of new drugs’ budget impact: analysis of a sample of recent US drug launches

Download Publication

2018

The potential value of rapid, cloud-enabled onsite testing for the diagnosis of rheumatoid arthritis in the United States

Download Publication

2018

Utilization and budget impact of tolvaptan in the inpatient setting among patients with heart failure and hyponatremia

Download Publication

2017

A systematic literature review of methods of incorporating mortality in cost effectiveness analyses of lipid-lowering therapies

Download Publication

2017

Budget Impact Analysis Comparing Aripiprazole and Aripiprazole Lauroxil Based on Real-World Dosing Patterns

Download Publication

2017

Budget Impact Analysis of Long-Acting Injectable Aripiprazole Once-Monthly 400 mg in Bipolar I Disorder

Download Publication

2017

Budget Impact of Increased Utilization of Palonosetron for the Control of Chemotherapy Induced Nausea and Vomiting in Managed Care

Download Publication

2017

Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals

Download Publication

2017

Cost Effectiveness of Bronchial Thermoplasty for Treatment of Severe Asthma Patients in Scotland

2017

Burden of Living with Migraine: Results for United States from the “My Migraine Voice” Survey

Early initiation of long-acting injectable antipsychotic treatment is associated with lower hospitalization rates and healthcare costs in patients with schizophrenia: real-world evidence from US claims data

Systematic bias in predictions of new drugs’ budget impact: analysis of a sample of recent US drug launches

Severity Classification for Sickle Cell Disease: A RAND/UCLA Modified Delphi Panel

Hospital Share of Profits from Physician-Administered Medicines

Projected Lifetime Clinical Value of a Multicancer Early Detection Test

Real-World Impact of Disease on Functioning and Activity: A Cross-Sectional Study of the National Health and Nutrition Examination Survey

The economic burden of caregiving in epilepsy: An estimate based on a survey of US caregivers

Costs associated with unplanned readmissions among patients with heart failure with and without hyponatremia

Healthcare Policy Changes in Osteoporosis Can Improve Outcomes and Reduce Costs in the United States

How does the Cox maze procedure compare? Cost-effectiveness analysis of alternative treatments of atrial fibrillation

Modeling the Mortality Impact of Budget Thresholds

Protecting the gains: What changes are needed to prevent a reversal of the downward cardiovascular disease mortality trend?

A Conversational War of Attrition

Bending the curve with patient identification and treatment in osteoporosis

Budget impact analysis of long-acting injectable aripiprazole once-monthly 400 mg in bipolar I disorder in the USA

Cost-effectiveness of long-acting injectable aripiprazole once-monthly 400 mg in bipolar I disorder in the USA

Defining Value-Based Pricing of Drugs

Systematic bias in predictions of new drugs’ budget impact: analysis of a sample of recent US drug launches

The potential value of rapid, cloud-enabled onsite testing for the diagnosis of rheumatoid arthritis in the United States

Utilization and budget impact of tolvaptan in the inpatient setting among patients with heart failure and hyponatremia

A systematic literature review of methods of incorporating mortality in cost effectiveness analyses of lipid-lowering therapies

Budget Impact Analysis Comparing Aripiprazole and Aripiprazole Lauroxil Based on Real-World Dosing Patterns

Budget Impact Analysis of Long-Acting Injectable Aripiprazole Once-Monthly 400 mg in Bipolar I Disorder

Budget Impact of Increased Utilization of Palonosetron for the Control of Chemotherapy Induced Nausea and Vomiting in Managed Care

Budget impact of somatostatin analogs as treatment for metastatic gastroenteropancreatic neuroendocrine tumors in US hospitals

Cost Effectiveness of Bronchial Thermoplasty for Treatment of Severe Asthma Patients in Scotland

Cost Effectiveness of Bronchial Thermoplasty for Treatment of Severe Asthma Patients in Spain